Kristen Fortney (BioAge) - Derisking Biotech by Stanford eCorner published on 2022-05-18T13:46:34Z Kristen Fortney is the co-founder and CEO of BioAge Labs, a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. In this conversation with Stanford adjunct lecturer Toby Corey, Fortney discusses strategies for reducing risk along the path to developing world-changing therapies. -------------------- Stanford eCorner content is produced by the Stanford Technology Ventures Program. At STVP, we empower aspiring entrepreneurs to become global citizens who create and scale responsible innovations. CONNECT WITH US Twitter: https://twitter.com/ECorner LinkedIn: https://www.linkedin.com/company/stanfordtechnologyventuresprogram/ Facebook: https://www.facebook.com/StanfordTechnologyVenturesProgram/ YouTube: https://www.youtube.com/user/ecorner LEARN MORE eCorner Website: https://ecorner.stanford.edu/ STVP Website: https://stvp.stanford.edu/ Support our mission of providing students and educators around the world with free access to Stanford University's network of entrepreneurial thought leaders: https://ecorner.stanford.edu/give. Genre Entrepreneurship Comment by Stanford eCorner Opportunities in Aging and Biotech 2022-05-18T14:23:12Z Comment by Stanford eCorner Bringing New Biotech Treatments to Market 2022-05-18T14:22:53Z Comment by Stanford eCorner Derisking Milestones in Biotech 2022-05-18T14:22:03Z